Remote exercise program for Hispanics/Latinos with multiple sclerosis

The Feasibility and Efficacy of a Remotely Delivered Exercise Training Intervention for the Hispanic/Latino Community With Multiple Sclerosis

NA · University of Illinois at Chicago · NCT05998616

This study is testing a 4-month online exercise program for Hispanics/Latinos with multiple sclerosis to see if it helps them feel better and improve their quality of life.

Quick facts

PhaseNA
Study typeInterventional
Enrollment50 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorUniversity of Illinois at Chicago (other)
Locations1 site (Chicago, Illinois)
Trial IDNCT05998616 on ClinicalTrials.gov

What this trial studies

This clinical trial investigates the feasibility and effectiveness of a 4-month remotely-delivered exercise training program specifically designed for Hispanics/Latinos with multiple sclerosis (MS). Participants will engage in flexibility, aerobic, and resistance training sessions guided by experienced coaches. The study aims to assess improvements in physical function, symptom management, and quality of life while also examining how social determinants of health impact the intervention's feasibility and effectiveness. A control group will be used for comparison to evaluate the significance of the exercise program's outcomes.

Who should consider this trial

Good fit: Ideal candidates are Hispanics/Latinos aged 18-65 with a diagnosis of MS who are relapse-free and currently insufficiently active.

Not a fit: Patients who are not Hispanic/Latino, have a diagnosis of MS but are too physically active, or do not meet other eligibility criteria may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could significantly improve physical function and quality of life for Hispanics/Latinos living with multiple sclerosis.

How similar studies have performed: While similar approaches have been explored, this specific focus on Hispanics/Latinos with MS and the integration of social determinants of health is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18-65 years
* Diagnosis of MS
* Relapse-free for at least 30 days
* Able to walk with or without an assistive device
* Insufficient physical activity (i.e., not meeting current physical activity guidelines of 150 minutes of moderate to vigorous physical activity per week)
* Willingness to complete all required testing procedures, outcome questionnaires, and randomization
* Identify as Hispanic/Latino
* Able to speak, read, and understand English
* Currently reside in Chicago
* Access to the internet and email
* Safe for exercise based on the Physical Activity Readiness Questionnaire (PAR-Q)

Exclusion Criteria:

* Not between 18-65 years
* No diagnosis of MS
* Not relapse-free for at least 30 days
* Not able to walk with or without an assistive device
* Too much physical activity (i.e. 150 minutes or more of moderate to vigorous physical activity per week)
* Not willing to complete all required testing procedures, outcome questionnaires, and randomization
* Do not identify as Hispanic/Latino
* Unable to speak, read, and understand English
* Not currently residing in Chicago
* No access to the internet and email
* Not safe for exercise based on the PAR-Q

Where this trial is running

Chicago, Illinois

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Multiple Sclerosis, Hispanics/Latinos, Exercise Intervention, Remote Exercise Training, Feasibility Study, Randomized Controlled Trial, Health Disparities, Social Determinants of Health

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.